| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |